NCT04898530

Brief Summary

The purpose of the study is to understand the diet patterns, preferences, and impact of diet on daily living in our patients with IBD in Central Texas.

Trial Health

33
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Trial recruitment is currently suspended
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 13, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 24, 2021

Completed
15 days until next milestone

Study Start

First participant enrolled

June 8, 2021

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

May 8, 2024

Status Verified

May 1, 2024

Enrollment Period

3.6 years

First QC Date

May 13, 2021

Last Update Submit

May 6, 2024

Conditions

Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis

Outcome Measures

Primary Outcomes (3)

  • diet patterns

    diet descriptions, ASA24

    6 months

  • diet preferences

    via questionnaires

    6 months

  • diet impact

    various outcomes

    6 months

Interventions

NO INTERVENTIONOTHER

There is no intervention for this study.

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients with inflammatory bowel disease

You may qualify if:

  • any patient 18years of age or older with inflammatory bowel disease

You may not qualify if:

  • unwilling to participate
  • diagnosis of IBD unable to be verified

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dell Medical School, UT Austin

Austin, Texas, 78712, United States

Location

MeSH Terms

Conditions

Inflammatory Bowel DiseasesCrohn DiseaseColitis, Ulcerative

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesColitisColonic Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Director of Inflammatory Bowel Diseases Center

Study Record Dates

First Submitted

May 13, 2021

First Posted

May 24, 2021

Study Start

June 8, 2021

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

May 8, 2024

Record last verified: 2024-05

Locations

US(1)